Determination of intranasal allergen threshold to egg in children with egg allergy

ISRCTN ISRCTN11376766
DOI https://doi.org/10.1186/ISRCTN11376766
Secondary identifying numbers 15942
Submission date
16/01/2014
Registration date
16/01/2014
Last edited
11/05/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms Christine Buicke
Scientific

Joint Research Compliance Office
Charing Cross Hospital
Fulham Palace Road
London
W6 8RF
United Kingdom

Phone +44 20 7589 5111
Email c.buicke@imperial.ac.uk

Study information

Study designNon-randomised; Interventional; Design type: Diagnosis, Not specified, Prevention
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeOther
Scientific titleDetermination of intranasal allergen threshold to egg in children with egg allergy
Study acronymINATE Study
Study objectivesDetermination of intranasal allergen threshold to egg in children with egg allergy
Ethics approval(s)14/WM/0016
Health condition(s) or problem(s) studiedTopic: Medicines for Children Research Network; Subtopic: All Diagnoses; Disease: All Diseases
InterventionPrimary Intervention, Sequential, incremental doses of aerosolised (food grade) egg white (egg protein) at 0, 0.1,
1, 10 and (where no symptoms are present) 100 µg per nostril (in sterile normal saline), at
30 minute intervals, using a nasal spray.
Intervention typeOther
Primary outcome measureImmediate allergic reaction (<30mins following administration)
Secondary outcome measuresNot provided at time of registration
Overall study start date06/01/2014
Completion date03/10/2014

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Years
Upper age limit17 Years
SexBoth
Target number of participantsPlanned Sample Size: 12; UK Sample Size: 12
Key inclusion criteria1. Aged 6 - 17 years old

2. Physiciandiagnosis of egg allergy on the basis of: Positive oral food challenge to egg (conducted under medical supervision) within the last 12 months OR History of convincing clinical reaction to egg within the last 12 months AND positive skin prick test within last 6 months OR Evidence of >95% likelihood of egg allergy (on the basis of serum specific IgE 6.0 IU/mL or above or skin prick test (SPT) 6mm or above to egg white within past 12 months but with no history of oral tolerance to egg
3. Written informed consent from parent/guardian, with assent from children aged 8 years and above wherever possible.
Key exclusion criteria1. Contraindicated as acutely unwell or current unstable asthma
1.1. Acute wheeze in last 72 hours requiring treatment
1.2. Febrile =380 deg C in last 72 hours
1.3. Recent admission to hospital in last 2 weeks for acute asthma
2. Current medication
2.1. Use of asthma reliever medication in last 72 hours
2.2. Recent administration of a medication containing antihistamine within the last 4 days
2.3. Current oral steroid for asthma exacerbation or course completed within last 2 weeks
Date of first enrolment06/01/2014
Date of final enrolment03/10/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Joint Research Compliance Office
London
W6 8RF
United Kingdom

Sponsor information

Imperial College London (UK)
University/education

Joint Research Compliance Office
Charing Cross Hospital
Fulham Palace Road
London
W6 8RF
England
United Kingdom

ROR logo "ROR" https://ror.org/041kmwe10

Funders

Funder type

Government

Public Health England (PHE) (UK)
Government organisation / National government
Alternative name(s)
PHE
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

11/05/2017: No publications found in PubMed, verifying study status with principal investigator